Literature DB >> 33310024

Oxygen metabolism markers as predictors of mortality in severe COVID-19.

Oleksandr V Oliynyk1, Marta Rorat2, Wojciech Barg3.   

Abstract

OBJECTIVE: The aim of this paper was to find oxygen metabolism markers that could predict mortality in patients with severe COVID-19.
METHODS: In a retrospective analysis we compared the medical records of patients with severe COVID-19 including 53 records of deceased patients and 50 records of survivors. The latter were selected from 222 records using a random number generator. For comparison, 28 individuals who considered themselves healthy and had no history of serious illness were also examined. Oxygen saturation in arterial blood (SaO2) and in central venous blood (ScvO2), arterial partial pressure of oxygen (PaO2), respiratory index (PaO2/FiO2), oxygen delivery (DO2), consumption (VO2) and extraction (O2ER) were compared in all participating individuals. Optimal cutoff point for oxygen parameters in prediction of death was performed using maximization of Youden Index in receiver operating characteristic (ROC) curve analysis.
RESULTS: There were statistically significant differences between values of all studied oxygen metabolism markers in the survivors as compared to the deceased patients (p < 0.001). ScvO2, VO2 and O2ER (AUC 1.0) were the strongest predictors of mortality, while PaO2 the lowest (0.81). ScvO2 < 29%, VO2 > 124.6 ml/min and O2ER > 30.2% were found to be predictors of mortality in patients with COVID-19.
CONCLUSION: Values of ScvO2, VO2 and O2ER appear to be good predictors of mortality in critically ill patients with COVID-19.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  ARDS; COVID-19; determinants of mortality; oxygen metabolism; respiratory failure

Year:  2020        PMID: 33310024     DOI: 10.1016/j.ijid.2020.12.012

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  3 in total

1.  Dynamic blood oxygen indices in mechanically ventilated COVID-19 patients with acute hypoxic respiratory failure: A cohort study.

Authors:  Luke Bracegirdle; Alexander Jackson; Ryan Beecham; Maria Burova; Elsie Hunter; Laura G Hamilton; Darshni Pandya; Clare Morden; Michael P W Grocott; Andrew Cumpstey; Ahilanandan Dushianthan
Journal:  PLoS One       Date:  2022-06-10       Impact factor: 3.752

2.  Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants.

Authors:  Oleksandr Oliynyk; Wojciech Barg; Yanina Oliynyk; Serhij Dubrov; Vitaliy Gurianov; Marta Rorat
Journal:  J Pers Med       Date:  2022-07-04

Review 3.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.